R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation

2006509 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Pharmacology and Experimental Therapeutics

Volume 319, Issue 3, pp. 998-1008

Field-Weighted Citation Impact: 6.39